Back to Basics: Designing digital patient services

Elisa del Galdo|2nd July 2015


 

Head of Customer Experience Elisa del Galdo talks through the key considerations for pharma companies when designing and delivering digital patient services from a customer experience perspective.

As pharma marketing departments increasingly look towards digital services and solutions, there are a number of important considerations that companies cannot afford to neglect. Understanding client objectives should be the first port of call. When talking about innovation in marketing, the creation of digital services and multi-platform offerings often comes up. There has been a great deal of innovation applied to the provision of digital services and solutions within the pharmaceutical industry, in spite of the unique challenges created by strict regulations on the marketing of medical products. That said, the design and development of customer-focused services and solutions is a relatively new approach in this sector.

 

To read more, download the full PDF of this article, as it appeared in the IPT Online - Innovations in Pharmaceutical Technology June 2015 issue.  

Precision paediatrics: Treating patients with CAR-T

Guest Blogger|9th July 2019

Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking CAR-T therapy for the first patient in Europe, and how the centre of excellence has adapted to make precision medicine a reality

read more

What does it mean to be an agile organisation

Guest Blogger|27th June 2019

We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market.

read more

Battling breast cancer with precision medicine (Part 2)

Natasha Cowan|20th June 2019

Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives his side of the story and explains how industry can help oncologists treat more patients with targeted therapies.

read more